There is no happy ending to the OxyContin epidemic. This drug has played a significant role in the broader opioid crisis, which claimed the lives of 645,000 Americans between 1999 and 2021. Although a nearly $6 billion settlement has been reached, aiming to offer assistance for drug addiction through counseling and therapy, as well as providing payouts to families who have lost loved ones to the painkiller, it only comes in the aftermath of a national affliction that has been wreaking havoc on the lives of individuals and communities for many years.
Meanwhile, the Sackler family, whose company Purdue Pharmaceuticals developed the drug and falsely marketed it as non-addictive, has been granted immunity from any future civil suits as part of this deal. With no criminal charges filed against them and still retaining billions of dollars in wealth, the Sacklers, according to the agreement, depart from the company they founded, which will be renamed Knoa Pharma. However, their family name and legacy are now synonymous with corporate greed and a callous disregard for human welfare on a very large scale.
